Skip to main content

Management of Hypertension in Cats

  • Chapter
  • First Online:
Hypertension in the Dog and Cat

Abstract

Before considering management of systemic hypertension, it is vital to ensure that an accurate and reliable diagnosis has been made by ruling out ‘false-positive’ and ‘false-negative’ diagnoses of hypertension. A detailed ophthalmic examination is often helpful in supporting a diagnosis of systemic hypertension. The main goals of treatment are to reduce the systolic blood pressure readings to an ‘ideal’ reference range (less than 140 mmHg) such that future target organ damage is prevented. Where possible efforts should be taken to identify and treat potential underlying/associated conditions such as chronic kidney disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Acierno MJ, Brown S, Coleman AE, Jepson RE, Papich M, Stepien RL, Syme HM (2018) ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 32(6):1803–1822

    Article  PubMed  PubMed Central  Google Scholar 

  • Amodip® Marketing Authorisation File 2015, on file at Ceva Animal Health

    Google Scholar 

  • Ash RA, Harvey AM, Tasker S (2005) Primary hyperaldosteronism in the cat: a series of 13 cases. J Feline Med Surg 7:173–182

    Article  PubMed  Google Scholar 

  • Belew A, Bartlett T, Brown SA (1999) Evaluation of the white-coat effect in cats. J Vet Intern Med 13:134–142

    Article  CAS  PubMed  Google Scholar 

  • Bijsmans ES, Jepson RE, Chang YM et al (2015) Changes in systolic blood pressure over time in healthy cats and cats with chronic kidney disease. J Vet Intern Med 29:855–861

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bijsmans ES, Doig M, Jepson RE et al (2016) Factors influencing the relationship between the dose of amlodipine required for blood pressure control and change in blood pressure in hypertensive cats. J Vet Intern Med 30:1630–1636

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bijsmans ES, Jepson RE, Wheeler C et al (2017) Plasma N-terminal pro-brain natriuretic peptide, vascular endothelial growth factor and cardiac troponin 1 as novel biomarkers of hypertensive disease and target organ damage in cats. J Vet Intern Med 31:650–660

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bisignano J, Bruyette DS (2012) Feline hyperaldosteronism: recognition and diagnosis. Vet Med 107:118–125

    Google Scholar 

  • Brown SA, Brown CA, Jacobs G et al (2001) Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency. Am J Vet Res 62:375–383

    Article  CAS  PubMed  Google Scholar 

  • Brown S, Atkins C, Bagley R et al (2007) Guidelines for the identification, evaluation, and Management of Systemic Hypertension in dogs and cats. J Vet Intern Med 21:542–558

    Article  CAS  PubMed  Google Scholar 

  • Brown AL, Beatty JA, Lindsay SA et al (2012) Severe systemic hypertension in a cat with pituitary-dependent hyperadrenocorticism. J Small Anim Pract 53:132–135

    Article  CAS  PubMed  Google Scholar 

  • Buranakarl C, Mathur S, Brown SA et al (2004) Effects of dietary sodium chloride intake on renal function and blood pressure in cats with normal and reduced renal function. Am J Vet Res 65:620–627

    Article  CAS  PubMed  Google Scholar 

  • Calsyn JD, Green RA, Davis GJ et al (2010) Adrenal pheochromocytoma with contralateral adrenocortical adenoma in a cat. J Am Anim Hosp Assoc 46:36–42

    Article  PubMed  Google Scholar 

  • Caney SMA. Ocular manifestations of systemic hypertension (2018). A free to download guide on www.vetprofessionals.com

    Chapter  Google Scholar 

  • Carter JM, Irving AC, Bridges JP et al (2014) The prevalence of ocular lesions associated with hypertension in an population of geriatric cats in New Zealand. N Z Vet J 62:21–29

    Article  CAS  PubMed  Google Scholar 

  • Chalhoub S, Langston CE, Farrelly J (2012) The use of Darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases. J Vet Intern Med 26:363–369

    Article  CAS  PubMed  Google Scholar 

  • Chetboul V, Lefebvre HP, Pinhas C et al (2003) Spontaneous feline hypertension: clinical and echocardiographic abnormalities and survival rate. J Vet Intern Med 17:89–95

    PubMed  Google Scholar 

  • Chun R, Jakovljevic S, Morrison WB et al (1997) Apocrine gland adenocarcinoma and pheochromocytoma in a cat. J Am Anim Hosp Assoc 33:33–36

    Article  CAS  PubMed  Google Scholar 

  • Coleman AE, Brown SA, Stark M et al (2019a) Evaluation of orally administered telmisartan for the reduction of indirect systolic arterial blood pressure in awake, clinically normal cats. J Feline Med Surg 21(2):109–114

    Article  PubMed  Google Scholar 

  • Coleman AE, Brown SA, Traas AM, Bryson L, Zimmering T, Zimmerman A (2019b) Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: results of a double-blind, placebo-controlled, randomized clinical trial. J Vet Intern Med 33(2):478–488

    Article  PubMed  PubMed Central  Google Scholar 

  • Cowgill LD, James KM, Levy JK et al (1998) Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. J Am Vet Med Assoc 212:521–528

    CAS  PubMed  Google Scholar 

  • Elliott J, Barber PJ, Syme HM et al (2001) Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. J Small Anim Pract 42:122–129

    Article  CAS  PubMed  Google Scholar 

  • Elliott J, Fletcher M, Souttar K et al. Effect of concomitant amlodipine and benazepril therapy in the management of feline hypertension, 14th ECVIM CA congress 2004

    Google Scholar 

  • Glaus TM, Elliott J, Herberich E et al (2019) Efficacy of long-term oral telmisartan treatment in cats with hypertension: results of a prospective European clinical trial. J Vet Intern Med 33(2):413–422

    Article  PubMed  Google Scholar 

  • Helms SR (2007) Treatment of feline hypertension with transdermal amlodipine: a pilot study. J Am Anim Hosp Assoc 43:149–156

    Article  PubMed  Google Scholar 

  • Henik RA, Snydrer PS, Volk LM (1997) Treatment of systemic hypertension in cats with amlodipine besylate. J Am Anim Hosp Assoc 33:226–234

    Article  CAS  PubMed  Google Scholar 

  • Henry CJ, Brewer WG, Montgomery RD et al (1993) Clinical vignette – adrenal phaeochromocytoma in a cat. J Vet Intern Med 7:199–201

    Article  CAS  PubMed  Google Scholar 

  • Huhtinen M, Derre G, Renoldi HJ et al (2015) Randomised placebo controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client owned cats. J Vet Intern Med 29:786–793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jarraya F (2017) Treatment of hypertension: which goal for which patient. Adv Exp Med Biol 956:117–127

    Article  PubMed  Google Scholar 

  • Javadi S, Djajadiningrat-Laanen SC, Kooistra HS et al (2005) Primary hyperaldosteronism, a mediator of progressive renal disease in cats. Domest Anim Endocrinol 28:85–104

    Article  CAS  PubMed  Google Scholar 

  • Jenkins TL, Coleman AE, Schmiedt CW et al (2015) Attenuation of the pressor response to exogenous angiotensin by angiotensin receptor blockers and benazepril hydrochloride in clinically normal cats. Am J Vet Res 76:807–813

    Article  CAS  PubMed  Google Scholar 

  • Jepson RE, Elliott J, Brodbelt D et al (2007) Effect of control of systolic blood pressure on survival in cats with systemic hypertension. J Vet Intern Med 21:402–409

    Article  PubMed  Google Scholar 

  • Jepson RE, Syme HM, Elliott J (2014) Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotaemia and in response to treatment with amlodipine besylate. J Vet Intern Med 28:144–153

    Article  CAS  PubMed  Google Scholar 

  • Kobayashi DL, Peterson ME, Graves TK et al (1990) Hypertension in cats with chronic renal failure or hyperthyroidism. J Vet Intern Med 4:58–62

    Article  CAS  PubMed  Google Scholar 

  • Lalor SM, Connolly DJ, Elliott J et al (2009) Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease. J Vet Cardiol 11(Suppl 1):S71–S79

    Article  PubMed  Google Scholar 

  • Littman MP (1994) Spontaneous systemic hypertension in 24 cats. J Vet Intern Med 8:79–86

    Article  CAS  PubMed  Google Scholar 

  • Maggio F, DeFrancesco TC, Atkins CE et al (2000) Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-1998). J Am Vet Med Assoc 217:695–702

    Article  CAS  PubMed  Google Scholar 

  • Mathur S, Syme H, Brown CA et al (2002) Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency. Am J Vet Res 63:833–839

    Article  CAS  PubMed  Google Scholar 

  • Morrow LD, Adams VJ, Elliott J et al (2009) Hypertension in hyperthyroid cats: prevalence, incidence and predictors of its development (abstract). J Vet Intern Med 23:699

    Google Scholar 

  • Patnaik AK, Erlandson RA, Lieberman PH et al (1990) Extra-adrenal pheochromocytoma (paraganglioma) in a cat. J Am Vet Med Assoc 197:104–106

    CAS  PubMed  Google Scholar 

  • Payne JR, Brodbelt DC, Fuentes V (2017) Blood pressure measurements in 780 apparently healthy cats. J Vet Intern Med 31:15–21

    Article  CAS  PubMed  Google Scholar 

  • Peterson ME (2013) More than just T4: diagnostic testing for hyperthyroidism in cats. J Feline Med Surg 15:767–777

    Article  Google Scholar 

  • Peterson ME, Guterl JN, Nichols R, Rishniw M (2015) Evaluation of serum thyroid-stimulating hormone concentration as a diagnostic test for hyperthyroidism in cats. J Vet Intern Med 29(5):1327–1334.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sansom J, Barnett KC, Dunn KA et al (1994) Ocular disease associated with hypertension in 16 cats. J Small Anim Pract 35:604–611

    Article  Google Scholar 

  • Sansom J, Rogers K, Wood JLN (2004) Blood pressure assessment in healthy cats and cats with hypertensive retinopathy. Am J Vet Res 65:245–252

    Article  PubMed  Google Scholar 

  • Simpson KM, De Risio L, Theobald A et al (2014) Feline ischaemic myelopathy with a predilection for the cranial cervical spinal cord in older cats. J Feline Med Surg 16:1001–1006

    Article  PubMed  Google Scholar 

  • Snyder PS (1998) Amlodipine: a randomized, blinded clinical trial in 9 cats with systemic hypertension. J Vet Intern Med 12:157–162

    Article  CAS  PubMed  Google Scholar 

  • Snyder PS, Sadek D, Jones GL (2001) Effect of amlodipine on echocardiographic variables in cats with systemic hypertension. J Vet Intern Med 15:52–56

    Article  CAS  PubMed  Google Scholar 

  • Sparkes AH, Caney SMA, King MCA et al (1999) Inter- and intraindividual variation in Doppler ultrasonic indirect blood pressure measurements in healthy cats. J Vet Intern Med 13:314–318

    CAS  PubMed  Google Scholar 

  • Steele JL, Henik RA, Stepien RL (2002) Effects of angiotensin converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease. Vet Ther 3(2):157–166

    PubMed  Google Scholar 

  • Stepien RL (2011) Feline systemic hypertension: diagnosis and management. J Feline Med Surg 13:35–43

    Article  PubMed  Google Scholar 

  • Stiles J, Polzin DJ, Bistner SI (1994) The prevalence of retinopathy in cats with systemic hypertension and chronic renal failure or hyperthyroidism. J Am Vet Med Assoc 30:564–572

    Google Scholar 

  • Syme HM, Elliott J (2003) The prevalence of hypertension in hyperthyroid cats at diagnosis and following treatment (abstract). J Vet Intern Med 17:754

    Google Scholar 

  • Syme HM, Barber PJ, Markwell PJ et al (2002) Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. J Am Vet Med Assoc 220:1799–1804

    Article  PubMed  Google Scholar 

  • Taylor SS, Sparkes AH, Briscoe K et al (2017) ISFM consensus guidelines on the diagnosis and management of hypertension in cats. J Feline Med Surg 19:288–303

    Article  PubMed  Google Scholar 

  • Theobald A, Volk HA, Dennis R et al (2013) Clinical outcome in 19 cats with clinical and magnetic resonance imaging diagnosis of ischaemic myelopathy (2000-2011). J Feline Med Surg 15:132–141

    Article  PubMed  Google Scholar 

  • Watanabe T, Mishina M (2007) Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure. J Vet Med Sci 69:1015–1023

    Article  CAS  PubMed  Google Scholar 

  • Williams TL, Peak KJ, Brodbelt D et al (2010) Survival and the development of azotaemia after treatment of hyperthyroid cats. J Vet Intern Med 24:863–869

    Article  CAS  PubMed  Google Scholar 

  • Wimpole JA, Adagra CF, Billson MF et al (2010) Plasma free metanephrines in healthy cats, cats with non-adrenal disease and a cat with suspected phaeochromocytoma. J Feline Med Surg 12:435–440

    Article  PubMed  Google Scholar 

  • Young WM, Zheng C, Davidson MG et al (2019) Visual outcome in cats with hypertensive chorioretinopathy. Vet Ophthalmol 22:161–167

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah M. A. Caney .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Caney, S.M.A. (2020). Management of Hypertension in Cats. In: Elliott, J., Syme, H., Jepson, R. (eds) Hypertension in the Dog and Cat. Springer, Cham. https://doi.org/10.1007/978-3-030-33020-0_12

Download citation

Publish with us

Policies and ethics